Acp-103-056
ClinicalTrials.gov NCT04164758
Research payments
$538,299
Through program year 2021, $538,299 in research payments was reported against Acp-103-056, across 178 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT04164758
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $129,183 | 35 |
| 2020 | Research | $263,489 | 52 |
| 2019 | Research | $145,627 | 91 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kore Liow Kailua, HI Named on 13 payments
- John Hemphill Savannah, GA Named on 11 payments
- Mark Hernandez Hialeah, FL Named on 10 payments
- Richard Singer Pembroke Pines, FL Named on 9 payments
- Stuart Shafer Vero Beach, FL Named on 9 payments
- Jose Gamez Hialeah, FL Named on 8 payments
- Nicklesh Thakur Sacramento, CA Named on 4 payments
- Ann Killoran Iowa City, IA Named on 4 payments
- Ashok Patel Toms River, NJ Named on 3 payments
- Lawrence Elmer Toledo, OH Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.